ErbB2/Her2 Antibody MAB1129-100 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemErbB2/Her2 Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberMAB1129-100
Quantity100 ug (also 500 ug, 25 ug)
ApplicationsWestern Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF-ready, ELISA Capture (Matched Antibody Pair)
Conjugate/TagUnconjugated
FormatLyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
ReactivityHuman
TargetErbB2/Her2
IsotypeIgG2b
Clone191924
HostMouse
ImmunogenMouse myeloma cell line NS0-derived recombinant human ErbB2/Her2, Thr23-Thr652, Accession # P04626
NCBI Full Gene Nameerb-b2 receptor tyrosine kinase 2
NCBI Gene Aliasesc-ERB-2, NGL, MLN-19, CD340, VSCN2, TKR1, HER-2, p185(erbB2), HER2, NEU, HER-2/neu, MLN 19, c-ERB2
ClonalityMonoclonal
ConcentrationLYOPH
Brand/TrademarkR&D Systems, a Bio-Techne Brand
PurityProtein A or G purified from hybridoma culture supernatant
Antibody TypePrimary Antibodies
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution

Available conjugates: Unconjugated

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(1) Contextual reprogramming of CAR-T cells for treatment of HER2⁺ cancersJournal of translational medicineNovember 7, 2021Yang Z, Li L, Turkoz A, Chen P, Harari-Steinfeld R, Bobbin M, Stefanson O, Choi H, Pietrobon V, Alphson B, et al.

(2) HER2-mediated enhancement of Ebola virus entryPLoS pathogensOctober 1, 2020Kuroda M, Halfmann P, Kawaoka Y.

(5) CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genomeNature biotechnologyJune 1, 2017Klann TS, Black JB, Chellappan M, Safi A, Song L, Hilton IB, Crawford GE, Reddy TE, Gersbach CA.

(6) HER2 and EGFR Overexpression Support Metastatic Progression of Prostate Cancer to BoneCancer researchJanuary 1, 2017Day KC, Lorenzatti Hiles G, Kozminsky M, Dawsey SJ, Paul A, Broses LJ, Shah R, Kunja LP, Hall C, Palanisamy N, et al.

(7) Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two MethodsDisease markersJanuary 1, 2017Fina E, Necchi A, Bottelli S, Reduzzi C, Pizzamiglio S, Iacona C, Daidone MG, Verderio P, Cappelletti V.

(8) Microbead arrays for the analysis of ErbB receptor tyrosine kinase activation and dimerization in breast cancer cellsAssay and drug development technologiesFebruary 1, 2010Khan IH, Zhao J, Ghosh P, Ziman M, Sweeney C, Kung HJ, Luciw PA.

ErbB2/Her2 Antibody